267 related articles for article (PubMed ID: 24244294)
1. The role of nuclear β-catenin accumulation in the Twist2-induced ovarian cancer EMT.
Mao Y; Xu J; Li Z; Zhang N; Yin H; Liu Z
PLoS One; 2013; 8(11):e78200. PubMed ID: 24244294
[TBL] [Abstract][Full Text] [Related]
2. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
3. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
[TBL] [Abstract][Full Text] [Related]
4. Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma.
Li Y; Wang W; Wang W; Yang R; Wang T; Su T; Weng D; Tao T; Li W; Ma D; Wang S
Gynecol Oncol; 2012 Jan; 124(1):112-8. PubMed ID: 22018873
[TBL] [Abstract][Full Text] [Related]
5. Significance of heterogeneous Twist2 expression in human breast cancers.
Mao Y; Zhang N; Xu J; Ding Z; Zong R; Liu Z
PLoS One; 2012; 7(10):e48178. PubMed ID: 23133563
[TBL] [Abstract][Full Text] [Related]
6. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.
Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J
J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802
[TBL] [Abstract][Full Text] [Related]
7. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.
Yan D; Avtanski D; Saxena NK; Sharma D
J Biol Chem; 2012 Mar; 287(11):8598-612. PubMed ID: 22270359
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
[TBL] [Abstract][Full Text] [Related]
9. Twist1/2 activates MMP2 expression via binding to its promoter in colorectal cancer.
Lu K; Dong JL; Fan WJ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8210-8219. PubMed ID: 30556860
[TBL] [Abstract][Full Text] [Related]
10. PCNP promotes ovarian cancer progression by accelerating β-catenin nuclear accumulation and triggering EMT transition.
Dong P; Fu H; Chen L; Zhang S; Zhang X; Li H; Wu D; Ji X
J Cell Mol Med; 2020 Jul; 24(14):8221-8235. PubMed ID: 32548978
[TBL] [Abstract][Full Text] [Related]
11. Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence.
Wang T; Li Y; Wang W; Tuerhanjiang A; Wu Z; Yang R; Yuan M; Ma D; Wang W; Wang S
Hum Pathol; 2014 Sep; 45(9):1839-46. PubMed ID: 24974259
[TBL] [Abstract][Full Text] [Related]
12. The correlation between TWIST, E-cadherin, and beta-catenin in human bladder cancer.
Shen CH; Wu JD; Jou YC; Cheng MC; Lin CT; Chen PC; Tseng YS; Shi CS; Chen SY; Chang DC; Lee YR
J BUON; 2011; 16(4):733-7. PubMed ID: 22331730
[TBL] [Abstract][Full Text] [Related]
13. Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells.
Wu Y; Ginther C; Kim J; Mosher N; Chung S; Slamon D; Vadgama JV
Mol Cancer Res; 2012 Dec; 10(12):1597-606. PubMed ID: 23071104
[TBL] [Abstract][Full Text] [Related]
14. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
[TBL] [Abstract][Full Text] [Related]
15. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
[TBL] [Abstract][Full Text] [Related]
16. FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer.
Malgundkar SH; Burney I; Al Moundhri M; Al Kalbani M; Lakhtakia R; Okamoto A; Tamimi Y
BMC Cancer; 2020 May; 20(1):374. PubMed ID: 32366234
[TBL] [Abstract][Full Text] [Related]
17. Role of TWIST2, E-cadherin and Vimentin in epithelial ovarian carcinogenesis and prognosis and their interaction in cancer progression.
Li X; Yang J; Wang X; Li X; Liang J; Xing H
Eur J Gynaecol Oncol; 2016; 37(1):100-8. PubMed ID: 27048119
[TBL] [Abstract][Full Text] [Related]
18. Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma.
Karbova E; Davidson B; Metodiev K; Tropé CG; Nesland JM
Int J Surg Pathol; 2002 Jul; 10(3):175-80. PubMed ID: 12232570
[TBL] [Abstract][Full Text] [Related]
19. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.
Douchi D; Ohtsuka H; Ariake K; Masuda K; Kawasaki S; Kawaguchi K; Fukase K; Oikawa M; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M
Cancer Lett; 2015 Aug; 365(1):132-40. PubMed ID: 26047573
[TBL] [Abstract][Full Text] [Related]
20. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
